Call to drop abacavir from use in adults
13 July 2025. Related: Journal scan, Antiretrovirals, Treatment strategies, Coinfections and complications.
Journal scan
Risk of metabolic syndrome when starting ART with bictegravir vs dolutegravir
7 June 2025. Related: Journal scan, Side effects, Weight, diabetes, metabolic complications.
Featured Latest news on the US crisis and its impact on global health
1 June 2025. Related: Journal scan, Special reports, Treatment access, Activism & advocacy.
Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV
27 May 2025. Related: Journal scan, mpox.
HIV activists in the US call for action in JID and Zachie Achmat brings South African perspective in the Lancet
26 May 2025. Related: Journal scan, Treatment access, Activism & advocacy.
Combining injectable lenacapavir and cabotegravir-LA
23 May 2025. Related: Journal scan, Antiretrovirals, Treatment strategies, Treatment access.
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025. Related: Journal scan, Treatment strategies, Drug resistance.
Lancet Commission on gender justice and equality
9 April 2025. Related: Journal scan.
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025. Related: Journal scan, Special reports, Treatment access.